Therapeutic Potential of Natural Products in Urolithiasis

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".

Deadline for manuscript submissions: 20 August 2024 | Viewed by 309

Special Issue Editor


E-Mail Website
Guest Editor
Programa de Pós-Graduação em Ciências Farmacêuticas, Núcleo de Investigações Químico-Farmacêuticas (NIQFAR), Universidade do Vale do Itajaí (UNIVALI), Campus Itajaí, Rua Uruguai 458, Centro, Santa Catarina CEP 88302-901, Brazil
Interests: natural products; bioactive compounds; kidney disease; hypertension; cardiovascular disease
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Kidney stones, also called nephrolithiasis or urolithiasis, are one of the most prevalent urological disorders, occasioned by the formation and sporadic movement of crystal agglomerates in the urinary tract. Their movement through the urinary tract can be incredibly painful, leading to medical emergencies. Pharmacological strategies aiming to relieve painful discomfort are primarily based on pain relievers, since there are no effective drugs that act on the dissolution of clusters. Surgical procedures may be required to remove or separate larger stones. In addition, urolithiasis is documented as a risk factor for other systemic ailments, such as cardiovascular and chronic kidney diseases. Considering this, there is an urgent demand for innovative treatments, with those obtained from natural products emphasized, owing to their inestimable supplies of metabolites with substantial therapeutic capacity.

This Special Issue will summarize the advantages of the natural products-based therapies presently investigated for urolithiasis and introduce potential nominees for innovative therapeutic development.

Dr. Priscila de Souza
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • natural products
  • plant extracts
  • isolated compounds from medicinal plants
  • kidney stone
  • nephrolithiasis
  • urinary tract
  • hypertension
  • diabetes
  • pain relievers

Published Papers

This special issue is now open for submission.
Back to TopTop